Changes in total serum bilirubin during phototherapy in late preterm and term infants with non-haemolytic hyperbilirubinemia

There is no standardized method for total serum bilirubin (TSB) monitoring during phototherapy for neonatal hyperbilirubinemia and national guidelines give heterogeneous indications.

Bibliographische Detailangaben
Veröffentlicht in:Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics. - 2014. - Amsterdam [u.a.]
1. Verfasser: Dani, Carlo (VerfasserIn)
Weitere Verfasser: Becciani, Sabrina (BerichterstatterIn), Pratesi, Simone (BerichterstatterIn)
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2019
Zugriff auf das übergeordnete Werk:Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics
Umfang:4
LEADER 01000caa a22002652 4500
001 ELV046192603
003 DE-627
005 20230624122058.0
007 cr uuu---uuuuu
008 191021s2019 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.earlhumdev.2019.02.007  |2 doi 
028 5 2 |a GBV00000000000559.pica 
035 |a (DE-627)ELV046192603 
035 |a (ELSEVIER)S0378-3782(18)30691-1 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
082 0 4 |a 610  |q VZ 
082 0 4 |a 610  |q VZ 
084 |a 44.45  |2 bkl 
100 1 |a Dani, Carlo  |e verfasserin  |4 aut 
245 1 0 |a Changes in total serum bilirubin during phototherapy in late preterm and term infants with non-haemolytic hyperbilirubinemia 
264 1 |c 2019 
300 |a 4 
336 |a nicht spezifiziert  |b zzz  |2 rdacontent 
337 |a nicht spezifiziert  |b z  |2 rdamedia 
338 |a nicht spezifiziert  |b zu  |2 rdacarrier 
520 |a There is no standardized method for total serum bilirubin (TSB) monitoring during phototherapy for neonatal hyperbilirubinemia and national guidelines give heterogeneous indications. 
700 1 |a Becciani, Sabrina  |4 oth 
700 1 |a Pratesi, Simone  |4 oth 
773 0 8 |i Enthalten in  |n Elsevier Science  |a Abdel-Aziz, Tarek Ezzat ELSEVIER  |t Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics  |d 2014  |g Amsterdam [u.a.]  |w (DE-627)ELV022803173 
773 1 8 |g volume:131  |g year:2019  |g pages:41-44  |g extent:4 
856 4 0 |u https://doi.org/10.1016/j.earlhumdev.2019.02.007  |3 Volltext 
912 |a GBV_USEFLAG_U 
912 |a GBV_ELV 
912 |a SYSFLAG_U 
912 |a SSG-OLC-PHA 
912 |a GBV_ILN_130 
912 |a GBV_ILN_350 
936 b k |a 44.45  |j Immunologie  |q VZ 
951 |a AR 
952 |d 131  |j 2019  |h 41-44  |g 4